NASDAQ:MRKR | EBITDA Margin | Marker Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2019-12-31 to 2023-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2023-03-31-282.85%
2022-12-31-293.17%
2022-03-31-955.95%
2019-12-31-2499.05%

Annual EBITDA Margin

DateEBITDA Margin
2022-12-31-483.90%
2021-12-31-3006.26%
2020-12-31-6084.21%
2019-12-31-10517.97%